Fertinex
CONTRAINDICATIONS
FertinexTM (urofollitropin for injection, purified) is contraindicated in women who exhibit :
1. High levels of FSH indicating primary ovarian failure.
2. Uncontrolled thyroid or adrenal dysfunction.
3. An organic intracranial lesion such as a pituitary tumor.
4. The presence of any cause of infertility other than anovulation, as stated in the "Indications" unless they are candidates for Assisted Reproductive Technologies.
5. Abnormal bleeding of undetermined origin (see INDICATIONS: Selection of Patients).
6. Ovarian cysts or enlargement of undetermined origin.
7. Prior hypersensitivity to urofollitropin.
FertinexTM is also contraindicated in women who are pregnant and may cause fetal harm when administered to a pregnant woman. There are limited human data on the effects of FertinexTM when administered during pregnancy.
Generic Name: Urofollitropin
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Trying to Conceive
Get tips and advances in treatment.
Acupuncture for Fertility
There are a number of high-tech fertility treatments available for couples trying to conceive. Now you can add one more to the list. See more WebMD Videos »
